Apr
18

6 Important Qualities to Look For in Hormone Replacement Training

Written by Krista Russ We have explored the pandemic of chronic illness that patients are experiencing. We have also explored how hormone replacement therapy can safely and effectively prevent or even treat many chronic illnesses by delving into the robust medical literature supporting hormone replacement. After learning how Bioidentical Hormone Replacement Therapy (BHRT) can help
DETAIL
Apr
14

What is BHRT and 5 ways it Could Benefit Your Patients

What is BHRT and 5 ways it Could Benefit Your Patients Written by Krista Russ Previously, we discussed how patients are taking more medications and experiencing an endless conundrum of health issues. The systemic failure to address the root causes of disease is a huge part of the problem. Along with the proven benefits of
DETAIL
Feb
08

Treating T3 Deficiency: Thyroid Optimization

By Neal Rouzier, MD High Dose Replacement with thyroid hormone DOES NOT cause harm as demonstrated in interventional studies. The harm of Graves’ disease should not be extrapolated to optimal replacement. Understanding the controversies of thyroid hormone levels and thyroid hormone replacement-that which AACE and your peers do not understand or realize. The last webinar
DETAIL
Jan
11

Treating T3 Deficiency: The Most Important of the Thyroid Webinars So Far

By Neal Rouzier, MD CASE: Your hormonally optimized 45 y/o female patient requests an office visit to discuss her thyroid hormone. Her PMD chastises her for taking thyroid hormone and states that he does not wish to see her anymore as a patient. She relates that upon routine testing of thyroid function, that the TSH
DETAIL
Aug
18

Controlling HgBA1C with Medications Does not Make Diabetes Disappear – It Lowers the Surrogate Marker HgBA1C

By Neal Rouzier, MD Table of Contents Introduction JAMA & NEJM Hormones and Beyond 2022September 16-18, 2022Virtual & In Person | Near Albuquerque, New Mexico Register Now Introduction My goal and intent of Hormones and Beyond 2021 was to introduce new and different concepts of insulin resistance and how it pertains to the development of CVD
By Deirdre Nitsche | Blog . HRT Evidence Based Literature
DETAIL
Aug
06

Treating T3 Deficiency: Recent Literature Supports That Low Free T3 was the Highest Independent Predictor of Death in CV Patients

Recommended Pre-Reading: Treating T3 Deficiency, The Evidence You Need Interested in monthly webinars? Upgrade your Membership SCENARIO: A 59 y/o female with CVD is referred by her friend for evaluation of hypothyroidism. Laboratory tests consistently show a mildly elevated TSH and normal Free T4. Despite multiple attempts to try to get her PMD to prescribe a trial
By Deirdre Nitsche | Blog . CVD . Disease . HRT Evidence Based Literature . Thyroid
DETAIL
Jul
29

Treating T3 Deficiency: More Proof and Reasoning that T4 Monotherapy Results in Inadequate Conversion and FINALLY the AACE releases a revised statement on Thyroid Treatment

Recommended Pre-Reading: Treating T3 Deficiency: If T4 Does not Improve Symptoms, and Normalizing TSH Does not Guarantee or Infer Improvement in Symptoms, Then How Should we Treat Patients? SCENARIO: A 45 y/o female with persistent symptoms of fatigue, low energy, depression, presents for evaluation of her thyroid hormone therapy. She is referred by her friend
DETAIL
Jul
27

Treating T3 Deficiency: If T4 Does not Improve Symptoms, and Normalizing TSH Does not Guarantee or Infer Improvement in Symptoms, Then How Should we Treat Patients?

Recommended Pre-Reading: Treating T3 Deficiency, The Evidence You Need SCENARIO: Your 41 y/o PCOS patient that is optimized on thyroid returns with concerns that her PMD does not like/approve of DTE. She notes that she is finally feeling well and experiencing success with weight loss. The PMD also is upset with the suppressed TSH level
DETAIL
Apr
23

Make a Difference in Patient Wellness with Hormone Therapy

Have you experienced the frustration of a patient who never seems to get better? You’ve diagnosed her with insulin resistance or even full-blown Type II Diabetes. You’ve counseled her on changing her diet.

DETAIL
Apr
08

Treating T3 Deficiency, the Evidence You Need

Your 45 y/o female patient that is now optimized on your HRT program returns for evaluation after her PMD voiced concerns about your treatment with thyroid hormone. 

DETAIL